久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

US FDA issues emergency use authorization for first COVID-19 vaccine

Xinhua | Updated: 2020-12-12 14:08
Share
Share - WeChat
In this file photo illustration taken on Nov 23, 2020, shows a syringe and a bottle reading "COVID-19 Vaccine" next to the Pfizer company logo. [Photo/Agencies]

WASHINGTON -- The US Food and Drug Administration (FDA) Friday issued authorization for emergency use of the first COVID-19 vaccine in the United States.

The first Emergency Use Authorization (EUA) was issued to the COVID-19 vaccine of American drugmaker Pfizer in partnership with German company BioNTech, allowing the vaccine to be distributed in the United States.

The FDA has determined that Pfizer-BioNTech COVID-19 vaccine has met the statutory criteria for issuance of an EUA. The totality of the available data provides clear evidence that Pfizer-BioNTech COVID-19 vaccine may be effective in preventing COVID-19, said the FDA in a statement.

The data also show that the known and potential benefits outweigh the known and potential risks, supporting the vaccine's use in millions of people 16 years of age and older, said the FDA.

"The FDA's authorization for emergency use of the first COVID-19 vaccine is a significant milestone in battling this devastating pandemic that has affected so many families in the United States and around the world," said FDA Commissioner Stephen Hahn.

"Today's action follows an open and transparent review process that included input from independent scientific and public health experts and a thorough evaluation by the agency's career scientists to ensure this vaccine met FDA's rigorous, scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization," he said in a statement.

The Pfizer-BioNTech vaccine contains a small piece of the SARS-CoV-2 virus's mRNA that instructs cells in the body to make the virus's distinctive "spike" protein.

When a person receives this vaccine, their body produces copies of the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2.

The vaccine is administered as a series of two doses, three weeks apart.

Global COVID-19 cases surpassed 70 million on Friday, according to the Center for Systems Science and Engineering at Johns Hopkins University. The United States reported the most cases and deaths around the world as of 4:28 pm local time (2128 GMT), numbering 15,758,661 and 293,785, respectively.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产免费人视频在线观看免费 | 99久久精品男女性高爱 | 欧美另类亚洲一区二区 | 俄罗斯美女在线观看一区 | 免费人成观看在线网 | 印度最猛性ⅹxxxxx | 日本精品一在线观看视频 | 欧美亚洲另类久久综合 | 成人网18免费网站在线 | 日本阿v视频在线观看高清 日本波多野结衣视频 | 欧美韩国日本 | 国产精品久久久一区二区三区 | avtt亚洲一区中文字幕 | 日本特黄特色高清免费视频 | 成人免费久久精品国产片久久影院 | 日本三级香港三级人妇gg在线 | 欧美一区综合 | 亚洲精品在线影院 | 日本欧美久久久久免费播放网 | 成年人在线视频免费观看 | 综合久久91| 三级黄a| 国产免费一区二区三区 | 在线一区二区三区 | 国产亚洲亚洲精品777 | 黄片毛片在线观看 | 久久99亚洲精品久久频 | 99久久香蕉 | 精品国产欧美另类一区 | 日本免费人成在线网站 | 久久精品视频在线观看 | 一区二区三区久久 | 国产福利拍拍拍 | 美国三级网站 | 99je全部都是精品视频在线 | 日本欧美片 | 日本一区视频在线观看 | 欧美成人免费tv在线播放 | 日本久久综合 | 欧美黄色一级在线 | 毛片直接看|